Biosimilar eye drug Yesafili gets green light for Canadian market entry in 2025
INDIA—Biocon Biologics Ltd., a subsidiary of Biocon Ltd. and a globally integrated biosimilars...
Read MoreSelect Page
by Editor | Mar 6, 2024 | LATEST NEWS, Pharmaceuticals & Manufacturing | 0
INDIA—Biocon Biologics Ltd., a subsidiary of Biocon Ltd. and a globally integrated biosimilars...
Read Moreby Editor | Sep 19, 2023 | LATEST NEWS, People News, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
INDIA – The Board of Directors of Biocon, a global biopharmaceutical company, has approved the...
Read Moreby Editor | Sep 7, 2023 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
INDIA – Biocon Biologics has finalized the integration of the acquired biosimilars business from...
Read Moreby Editor | Dec 4, 2022 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
INDIA — Biocon has announced the signing of a semi-exclusive partnership agreement with Zentiva, a...
Read Moreby Editor | Dec 4, 2022 | LATEST NEWS, Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
INDIA — Biosimilars manufacturing arm of Biocon Ltd, Biocon Biologics, has completed the...
Read Moreby Editor | May 20, 2022 | Government, Regulatory & Policy News, LATEST NEWS, WORLD NEWS | 0
INDIA – The Competition Commission of India (CCI) has approved the merger of Covidshield...
Read Moreby Editor | Apr 27, 2022 | Hospitals, LATEST NEWS, Medical Devices & Innovations, WORLD NEWS | 0
MALAYSIA – The Malaysian government has awarded Biocon Biologics’ subsidiary a contract...
Read Moreby Editor | Sep 17, 2021 | LATEST NEWS, WORLD NEWS | 0
INDIA – Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life...
Read More